Niagen Bioscience, Inc. (NAGE) is a Healthcare · Biotechnology company listed on NASDAQ. Price $3.00 (+0.33%), Market cap $0.31B, P/E ratio 18.33, 52-week low–high $3.76 ~ $14.41.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nic
Financial statements, price targets, institutional (13F) holdings and related news for Niagen Bioscience, Inc. are updated in real time on BlackAll Trade.
Niagen Bioscience, Inc. trades at $3.00 (+0.33%). Real-time quotes and charts are available on BlackAll Trade.
Niagen Bioscience, Inc. has a market cap of about $0.31B. Its P/E ratio is 18.33.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It prov